Literature DB >> 6204768

The structure of an antigenic determinant in a protein.

I A Wilson, H L Niman, R A Houghten, A R Cherenson, M L Connolly, R A Lerner.   

Abstract

The immunogenic and antigenic determinants of a synthetic peptide and the corresponding antigenic determinants in the parent protein have been elucidated. Four determinants have been defined by reactivity of a large panel of antipeptide monoclonal antibodies with short, overlapping peptides (7-28 amino acids), the immunizing peptide (36 amino acids), and the intact parent protein (the influenza virus hemagglutinin, HA). The majority of the antipeptide antibodies that also react strongly with the intact protein recognize one specific nine amino acid sequence. This immunodominant peptide determinant is located in the subunit interface in the HA trimeric structure. The relative inaccessibility of this site implies that antibody binding to the protein is to a more unfolded HA conformation. This antigenic determinant differs from those previously described for the hemagglutinin and clearly demonstrates the ability of synthetic peptides to generate antibodies that interact with regions of the protein not immunogenic or generally accessible when the protein is the immunogen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204768     DOI: 10.1016/0092-8674(84)90412-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  323 in total

1.  The role of the 3-hydroxy 3-methylglutaryl coenzyme A reductase cytosolic domain in karmellae biogenesis.

Authors:  D A Profant; C J Roberts; A J Koning; R L Wright
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

2.  Construction of a pseudoreceptor that mediates transduction by adenoviruses expressing a ligand in fiber or penton base.

Authors:  D A Einfeld; D E Brough; P W Roelvink; I Kovesdi; T J Wickham
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

3.  The Kex2p proregion is essential for the biosynthesis of an active enzyme and requires a C-terminal basic residue for its function.

Authors:  G Lesage; A Prat; J Lacombe; D Y Thomas; N G Seidah; G Boileau
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

4.  Conserved composition of mammalian box H/ACA and box C/D small nucleolar ribonucleoprotein particles and their interaction with the common factor Nopp140.

Authors:  Y Yang; C Isaac; C Wang; F Dragon; V Pogacic; U T Meier
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

5.  The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.

Authors:  C E Andoniou; N L Lill; C B Thien; M L Lupher; S Ota; D D Bowtell; R M Scaife; W Y Langdon; H Band
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

6.  Differential responses of Escherichia coli cells expressing cytoplasmic domain mutants of penicillin-binding protein 1b after impairment of penicillin-binding proteins 1a and 3.

Authors:  C Chalut; X Charpentier; M H Remy; J M Masson
Journal:  J Bacteriol       Date:  2001-01       Impact factor: 3.490

7.  Transmembrane insertion of the Toxoplasma gondii GRA5 protein occurs after soluble secretion into the host cell.

Authors:  L Lecordier; C Mercier; L D Sibley; M F Cesbron-Delauw
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

8.  HAM: a new epitope-tag for in vivo protein labeling.

Authors:  A Herbst; W P Tansey
Journal:  Mol Biol Rep       Date:  2000       Impact factor: 2.316

9.  Construction and application of epitope- and green fluorescent protein-tagging integration vectors for Bacillus subtilis.

Authors:  Marcus Kaltwasser; Thomas Wiegert; Wolfgang Schumann
Journal:  Appl Environ Microbiol       Date:  2002-05       Impact factor: 4.792

10.  Assembly of protein kinase CK2: investigation of complex formation between catalytic and regulatory subunits using a zinc-finger-deficient mutant of CK2beta.

Authors:  D A Canton; C Zhang; D W Litchfield
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.